April 19, 2017 Acad, Gov/Utilities Bio/Pharma/CRO PR/Corporate

Roche to present new data at AAN reinforcing efficacy and safety of newly FDA-approved OCREVUS™ (ocrelizumab) in two types of multiple sclerosis

Basel, 19 April 2017 Roche to present new data at AAN reinforcing efficacy and safety of newly FDA-approved OCREVUS™ (ocrelizumab) in two types of multiple sclerosis Data presentations will include platform sessions and posters across relapsing multiple sclerosis and primary progressive multiple sclerosis Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data on... Read more

April 18, 2017 Microscopy PR/Corporate

Park Systems, World Leader Manufacturer of Atomic Force Microscopes Announces Opening of European Headquarters in Heidelberg, Germany

SANTA CLARA, Calif., April 18, 2017 /PRNewswire/ — Park Systems, world-leader in atomic force microscopy (AFM) recently announced the opening of their European Headquarters in Heidelberg, Germany and appointment of Ludger Weisser as General Manager. Park Systems is a publicly traded company listed on KOSDAQ since 2015 where they received “AA” from two separate rating agencies... Read more

April 17, 2017 Bio/Pharma/CRO Clinical Research/Diagn. Life Science Tools M&A, Partnerships PR/Corporate

Transgenomic Closes Bridge Financing

Proceeds Intended to Facilitate Completion of Merger with Precipio Diagnostics During Second Quarter of 2017 OMAHA, Neb. (April 17, 2017) — Transgenomic, Inc. (OTCQB: TBIO) today reported that it has received $1.15 million in proceeds from a note bridge financing.The financing is intended to help facilitate the completion of Transgenomic’s merger with Precipio Diagnostics, LLC,... Read more

April 17, 2017 Clinical Research/Diagn. Environ, Ag./Food & Bev PR/Corporate

Two Pore Guys Recruits Jordan Hubbard as VP of Engineering

Tech Industry Veteran to Drive Strategy Combining Hand-held Diagnostics with Big Data April 17, 2017 04:30 AM Pacific Daylight Time SANTA CRUZ, Calif.–(BUSINESS WIRE)–Two Pore Guys, Inc., (2PG) today announced that Jordan Hubbard has joined 2PG as Vice President of Engineering, overseeing both the software and hardware development of the company’s flagship product — a... Read more

April 11, 2017 Bio/Pharma/CRO Informatics & Software Lab Top-10 Mass Spectrometry PR/Corporate Uncategorized

Companies collaborate at Danaher Life Sciences Biologics Day to present the latest technological developments for biopharmaceutical analysis

SCIEX features its ground-breaking biologics solutions including the X500B QTOF System and the Fast Glycan Labeling and Analysis Kit April 11, 2017 Framingham, MA — SCIEX, a Danaher company and global leader in life science analytical technologies, today announced that it presented the company’s latest ground-breaking biologics solutions at the Danaher Life Sciences Biologics Day.... Read more

April 10, 2017 Environ, Ag./Food & Bev PR/Corporate

Roka Bioscience to participate in the 40th Annual National Food Policy Conference

Roka Bioscience to participate in the 40th Annual National Food Policy Conference WARREN, N.J., April 10, 2017 /PRNewswire/ — Roka Bioscience, Inc. (NASDAQ: ROKA), a molecular diagnostics company focused on providing advanced testing solutions for the detection of foodborne pathogens, announced today that Dr. Erin Dreyling, Vice President, Research & Scientific Affairs at Roka Bioscience... Read more

April 10, 2017 Bio/Pharma/CRO PR/Corporate

Phase III study shows Roche’s Alecensa was superior to crizotinib in a specific type of lung cancer

Basel, 10 April 2017 Phase III study shows Roche’s Alecensa was superior to crizotinib in a specific type of lung cancer Second Phase III head-to-head study that showed that Alecensa helped people with advanced ALK-positive non-small cell lung cancer (NSCLC) Results showed that people treated with Alecensa lived significantly longer without their disease progressing compared... Read more